Innovations in Bacteriophage Genome Engineering for Combating Multidrug-Resistant Bacterial Infections
Foodborne Pathogens and Disease · 2026
DOI: 10.1089/fpd.2024.0194 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Foodborne Pathogens and Disease, 2026. Verfasst von Riska Ayu Febrianti und 3 weiteren Autor:innen. Beteiligte Einrichtung: Doctoral Program of Biotechnology, Postgraduate Program, University of Jember, Jember, Indonesia. Hauptthemen laut MEDLINE: Bacteriophages, Drug Resistance, Multiple, Bacterial, Genetic Engineering, Phage Therapy. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 73 Literaturangaben.
Abstract (Originalsprache)
Bacteriophage engineering is a promising strategy to address multidrug-resistant (MDR) bacterial infections that pose significant challenges to public health due to the overuse of antibiotics. Bacteria can develop resistance mechanisms, such as receptor modification and activation of antiviral defense systems, which further complicates the application of phage therapy. Additionally, long-term phage therapy can result in the production of anti-phage antibodies, which may interfere with treatment. These factors require advanced engineering techniques to improve the efficacy of phages and expand their host range. Recent advances in genome engineering methods, including CRISPR/Cas9, homologous recombination, and other synthetic biology techniques, offer promising solutions to these challenges. By modifying receptor-binding proteins and using high-yield screening methods, researchers can create phages that are better equipped to target MDR bacteria effectively. Furthermore, understanding the intricate interactions between phages and their bacterial hosts is critical to guiding these engineering efforts. Future development perspectives lie in integrating these advanced engineering techniques into clinical practice, potentially putting bacteriophages at the forefront of fighting MDR bacterial infections.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Doctoral Program of Biotechnology, Postgraduate Program, University of Jember, Jember, Indonesia.
- Department of Agricultural Product Technology, University of Jember, Jember, Indonesia.
- Department of Biology Education, University of Jember, Jember, Indonesia.
ORCID-Profile: Erlia Narulita
Zitieren
APA
Febrianti, R. A., Narulita, E., Sulistyaningsih, E., & Addy, H. S. (2026). Innovations in Bacteriophage Genome Engineering for Combating Multidrug-Resistant Bacterial Infections. Foodborne Pathogens and Disease. https://doi.org/10.1089/fpd.2024.0194
Vancouver
Febrianti RA, Narulita E, Sulistyaningsih E, Addy HS. Innovations in Bacteriophage Genome Engineering for Combating Multidrug-Resistant Bacterial Infections. Foodborne Pathogens and Disease. 2026. doi:10.1089/fpd.2024.0194
BibTeX
@article{Febrianti2026,
author = {Febrianti, Riska Ayu and Narulita, Erlia and Sulistyaningsih, Erma and Addy, Hardian Susilo},
title = {Innovations in Bacteriophage Genome Engineering for Combating Multidrug-Resistant Bacterial Infections},
journal = {Foodborne Pathogens and Disease},
year = {2026},
doi = {10.1089/fpd.2024.0194}
}
EUVIMED